Published in PLoS Genet on July 01, 2007
Diverse molecular functions of Hu proteins. Cell Mol Life Sci (2008) 4.09
The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA (2011) 1.54
A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet (2010) 1.48
Genetics of complex neurological disease: challenges and opportunities for modeling epilepsy in mice and rats. Trends Genet (2009) 1.25
MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res (2009) 1.13
Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis (2010) 1.11
CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet (2012) 1.07
The relevance of individual genetic background and its role in animal models of epilepsy. Epilepsy Res (2011) 1.04
The role of CELF proteins in neurological disorders. RNA Biol (2010) 1.00
Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans. Nucleic Acids Res (2013) 0.99
CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease. Mol Cell Neurosci (2012) 0.98
Szt2, a novel gene for seizure threshold in mice. Genes Brain Behav (2009) 0.95
Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice. J Physiol (2012) 0.92
CELF family RNA-binding protein UNC-75 regulates two sets of mutually exclusive exons of the unc-32 gene in neuron-specific manners in Caenorhabditis elegans. PLoS Genet (2013) 0.90
CELFish ways to modulate mRNA decay. Biochim Biophys Acta (2013) 0.87
Etiology of a genetically complex seizure disorder in Celf4 mutant mice. Genes Brain Behav (2011) 0.85
Genome-wide prediction and analysis of human tissue-selective genes using microarray expression data. BMC Med Genomics (2013) 0.83
Haploinsufficiency of CELF4 at 18q12.2 is associated with developmental and behavioral disorders, seizures, eye manifestations, and obesity. Eur J Hum Genet (2012) 0.82
CELF RNA binding proteins promote axon regeneration in C. elegans and mammals through alternative splicing of Syntaxins. Elife (2016) 0.82
RNA-binding proteins, neural development and the addictions. Genes Brain Behav (2016) 0.81
Unraveling genetic modifiers in the gria4 mouse model of absence epilepsy. PLoS Genet (2014) 0.81
Bruno protein contains an expanded RNA recognition motif. Biochemistry (2009) 0.80
Complex network analysis of CA3 transcriptome reveals pathogenic and compensatory pathways in refractory temporal lobe epilepsy. PLoS One (2013) 0.80
A targeted deleterious allele of the splicing factor SCNM1 in the mouse. Genetics (2008) 0.79
Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development. Stem Cells (2013) 0.78
Hidden in plain sight: spike-wave discharges in mouse inbred strains. Genes Brain Behav (2014) 0.77
Quantitative Nucleotide Level Analysis of Regulation of Translation in Response to Depolarization of Cultured Neural Cells. Front Mol Neurosci (2017) 0.75
Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02
R/qtl: QTL mapping in experimental crosses. Bioinformatics (2003) 22.38
An extensive network of coupling among gene expression machines. Nature (2002) 11.84
Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science (1998) 6.67
Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell (2001) 6.00
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 5.72
The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron (1995) 4.78
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature (1995) 4.36
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 4.25
Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet (2002) 3.73
Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med (1998) 2.89
Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science (1989) 2.61
Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell (2003) 2.46
SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science (2003) 2.34
Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci (1998) 2.09
A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron (2001) 2.05
Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol Cell Biol (2005) 2.03
Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet (2004) 1.98
Electroconvulsive thresholds of inbred mouse strains. Genomics (2001) 1.58
A possible docking and fusion particle for synaptic transmission. Nature (1995) 1.49
CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J Biol Chem (2004) 1.43
Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res (1990) 1.37
Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol (2005) 1.35
Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem (2001) 1.32
Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol (2006) 1.30
Two neuronal, nuclear-localized RNA binding proteins involved in synaptic transmission. Curr Biol (2003) 1.26
Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes (2003) 1.22
Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type. Ann Neurol (2001) 1.18
ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo. Nucleic Acids Res (2004) 1.16
Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett (1989) 1.15
Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat Genet (1995) 1.09
Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H/He and backcross mice. J Neurosci (2005) 1.04
Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia (2004) 0.98
Differential distributions of novel synaptotagmins: comparison to synapsins. Neuropharmacology (1995) 0.95
Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res (2001) 0.93
Mice deficient for RNA-binding protein brunol1 show reduction of spermatogenesis but are fertile. Mol Reprod Dev (2007) 0.88
Identification and characterization of murine Brunol4, a new member of the elav/bruno family. Cytogenet Genome Res (2002) 0.87
Seizures, not hippocampal neuronal death, provoke neurogenesis in a mouse rapid electrical amygdala kindling model of seizures. Neuroscience (2005) 0.86
Segregation analysis of cryptogenic epilepsy and an empirical test of the validity of the results. Am J Hum Genet (1997) 0.86
The N-ethylmaleimide-sensitive fusion protein (NSF) is preferentially expressed in the nervous system. FEBS Lett (1994) 0.85
Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol (1998) 0.83
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature (2002) 3.30
An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol (2005) 2.97
An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron (2006) 2.86
Mouse Phenome Database (MPD). Nucleic Acids Res (2006) 2.43
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet (2004) 2.32
Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve (2005) 1.75
Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene. Hum Mol Genet (2004) 1.73
The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem (2007) 1.70
A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy. Nat Neurosci (2011) 1.66
The genomic landscape shaped by selection on transposable elements across 18 mouse strains. Genome Biol (2012) 1.63
Mouse phenome database. Nucleic Acids Res (2008) 1.59
A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet (2010) 1.48
Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice. Hum Mol Genet (2009) 1.45
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent. Behav Brain Res (2002) 1.44
Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol (2004) 1.38
Large-scale mutagenesis of the mouse to understand the genetic bases of nervous system structure and function. Brain Res Mol Brain Res (2004) 1.36
Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. Hum Mol Genet (2008) 1.36
Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Hum Mol Genet (2006) 1.34
Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol Cell Neurosci (2005) 1.33
Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet (2005) 1.31
Implementing large-scale ENU mutagenesis screens in North America. Genetica (2004) 1.31
The mitochondrial protease AFG3L2 is essential for axonal development. J Neurosci (2008) 1.29
A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons. J Neurosci (2006) 1.24
Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics (2004) 1.23
Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration. J Neurosci (2009) 1.23
Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus. Neurobiol Dis (2010) 1.23
Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold. Hum Mol Genet (2003) 1.17
The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics (2002) 1.16
Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. Hum Mol Genet (2004) 1.15
Auditory brainstem responses in 10 inbred strains of mice. Brain Res (2006) 1.15
A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol Endocrinol (2008) 1.13
Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol (2003) 1.12
A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem (2005) 1.12
A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice. Hum Mol Genet (2010) 1.11
A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. Am J Hum Genet (2011) 1.11
Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J Neurosci (2014) 1.11
The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J (2008) 1.09
CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet (2012) 1.07
Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy. Hum Mol Genet (2011) 1.06
Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B. Am J Pathol (2009) 1.06
A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol Cell (2012) 1.05
Alterations in osteopontin modify muscle size in females in both humans and mice. Med Sci Sports Exerc (2013) 1.03
Moving forward with chemical mutagenesis in the mouse. J Physiol (2004) 1.03
Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet (2009) 1.02
Neuromuscular disease models and analysis. Methods Mol Biol (2010) 1.02
Age, experience and genetic background influence treadmill walking in mice. Physiol Behav (2008) 1.01
Functional characterization of fidgetin, an AAA-family protein mutated in fidget mice. Exp Cell Res (2004) 0.98
Carbonic anhydrase related protein 8 mutation results in aberrant synaptic morphology and excitatory synaptic function in the cerebellum. Mol Cell Neurosci (2007) 0.97
Interaction between fidgetin and protein kinase A-anchoring protein AKAP95 is critical for palatogenesis in the mouse. J Biol Chem (2006) 0.96
Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain. Hum Mol Genet (2005) 0.95
Understanding the muscular dystrophy caused by deletion of choline kinase beta in mice. Biochim Biophys Acta (2009) 0.94
Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13. Mamm Genome (2004) 0.94
Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6. Hum Mol Genet (2012) 0.94
Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival. Hum Mol Genet (2005) 0.94
Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel. Epilepsia (2004) 0.93
Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice. J Physiol (2012) 0.92
Genetic and phenotypic analysis of seizure susceptibility in PL/J mice. Mamm Genome (2004) 0.92
Genetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells. J Virol (2010) 0.92
MARF1 regulates essential oogenic processes in mice. Science (2012) 0.91
Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia (2014) 0.91
Genetic approaches to studying mouse models of human seizure disorders. Adv Exp Med Biol (2004) 0.90
A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. Proc Natl Acad Sci U S A (2005) 0.87
Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction. J Biol Chem (2013) 0.86
Rhabdomyosarcomas in aging A/J mice. PLoS One (2011) 0.86
Grey, a novel mutation in the murine Lyst gene, causes the beige phenotype by skipping of exon 25. Mamm Genome (2006) 0.85
Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma. Cancer Genet (2012) 0.84
Anisotropic regulation of Ankrd2 gene expression in skeletal muscle by mechanical stretch. FASEB J (2010) 0.84
A genome end-game: understanding gene function in the nervous system. Nat Neurosci (2004) 0.84
Differential expression of choline kinase isoforms in skeletal muscle explains the phenotypic variability in the rostrocaudal muscular dystrophy mouse. Biochim Biophys Acta (2009) 0.83
Modes and regulation of endocytic membrane retrieval in mouse auditory hair cells. J Neurosci (2014) 0.83
Phenotypic heterogeneity in the stargazin allelic series. Mamm Genome (2003) 0.82
Early mechanical dysfunction of the diaphragm in the muscular dystrophy with myositis (Ttnmdm) model. Am J Physiol Cell Physiol (2008) 0.82
A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.81
From ER to Eph receptors: new roles for VAP fragments. Cell (2008) 0.80
A targeted deleterious allele of the splicing factor SCNM1 in the mouse. Genetics (2008) 0.79
Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development. Stem Cells (2013) 0.78
Retroposon compensatory mechanism hypothesis not supported: Zfa knockout mice are fertile. Genomics (2003) 0.78
Genetic modifiers interact with Cpe(fat) to affect body weight, adiposity, and hyperglycemia. Physiol Genomics (2005) 0.78
Retrotransposon insertion in the T-cell acute lymphocytic leukemia 1 (Tal1) gene is associated with severe renal disease and patchy alopecia in Hairpatches (Hpt) mice. PLoS One (2013) 0.75
Introducing PLoS Genetics. PLoS Genet (2005) 0.75
PLoS Genetics turns three: looking back, looking ahead. PLoS Genet (2008) 0.75
Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene. J Immunol (2003) 0.75